Load evaluation of the da Vinci surgical system for transoral robotic surgery

2015 ◽  
Vol 9 (4) ◽  
pp. 315-319 ◽  
Author(s):  
Kazunori Fujiwara ◽  
Takahiro Fukuhara ◽  
Koji Niimi ◽  
Takahiro Sato ◽  
Hiroya Kitano
Keyword(s):  
Robotic Surgery ◽  
Da Vinci ◽  
Transoral Robotic Surgery ◽  
Da Vinci Surgical System ◽  
Vinci Surgical System ◽  
Load Evaluation ◽  
Surgical System

Transoral robotic surgery for sellar tumors: first clinical study

2017 ◽  
Vol 127 (4) ◽  
pp. 941-948 ◽  
Author(s):  
Dorian Chauvet ◽  
Stéphane Hans ◽  
Antoine Missistrano ◽  
Celeste Rebours ◽  
Wissame El Bakkouri ◽  
...  
Keyword(s):  
Side Effects ◽  
Robotic Surgery ◽  
Operative Time ◽  
Da Vinci ◽  
Sella Turcica ◽  
Transoral Robotic Surgery ◽  
Da Vinci Surgical System ◽  
The Mean ◽  
Vinci Surgical System ◽  
Surgical System

OBJECTIVEThe aim of this study was to confirm the feasibility of an innovative transoral robotic surgery (TORS), using the da Vinci Surgical System, for patients with sellar tumors. This technique was designed to offer a new minimally invasive approach, without soft-palate splitting, that avoids the rhinological side effects of classic endonasal approaches.METHODSThe authors performed a prospective study of TORS in patients with symptomatic sellar tumors. Specific anatomical features were required for inclusion in the study and were determined on the basis of preoperative open-mouth CT scans of the brain. The main outcome measure was sellar accessibility using the robot. Resection quality, mean operative time, postoperative changes in patients' vision, side effects, and complications were additionally reported.RESULTSBetween February and May 2016, 4 patients (all female, mean age 49.5 years) underwent TORS for resection of sellar tumors as participants in this study. All patients presented with symptomatic visual deficits confirmed as bitemporal hemianopsia. All tumors had a suprasellar portion and a cystic part. In all 4 cases, the operation was performed via TORS, without the need for a second surgery. Sella turcica accessibility was satisfactory in all cases. In 3 cases, tumor resection was complete. The mean operative time was 2 hours 43 minutes. Three patients had a significant visual improvement at Day 1. No rhinological side effects or complications in patients occurred. No pathological examination was performed regarding the fluid component of the tumors. There was 1 postoperative delayed CSF leak and 1 case of transient diabetes insipidus. Side effects specific to TORS included minor sore throat, transient hypernasal speech, and 1 case of delayed otitis media. The mean length of hospital stay and mean follow up were 8.25 days and 82 days, respectively.CONCLUSIONSTo our knowledge, this is the first report of the surgical treatment of sellar tumors by means of a minimally invasive TORS. This approach using the da Vinci Surgical System seems feasible and constitutes an innovative neurosurgical technique that may avoid the adverse side effects and technical disadvantages of the classic transsphenoidal route. Moreover, TORS allows an inferosuperior approach to the sella turcica, which is a key point, as the tumor is approached in the direction of its growth.

Feasibility of Reduced-Port Robotic Surgery for Myomectomy with the da Vinci Surgical System

2017 ◽  
Vol 24 (6) ◽  
pp. 926-931 ◽  
Author(s):  
Jeong Jin Kim ◽  
Chahien Choi ◽  
Su Hyun Nam ◽  
Woo Young Kim
Keyword(s):  
Robotic Surgery ◽  
Da Vinci ◽  
Da Vinci Surgical System ◽  
Reduced Port ◽  
Vinci Surgical System ◽  
Surgical System

FEASIBILITY STUDY OF INTRAOCULAR ROBOTIC SURGERY WITH THE da VINCI SURGICAL SYSTEM

Retina ◽  
2008 ◽  
Vol 28 (1) ◽  
pp. 154-158 ◽  
Author(s):  
DAN H. BOURLA ◽  
JEAN PIERRE HUBSCHMAN ◽  
MARTIN CULJAT ◽  
ANGELO TSIRBAS ◽  
ANURAG GUPTA ◽  
...  
Keyword(s):  
Robotic Surgery ◽  
Feasibility Study ◽  
Da Vinci ◽  
Da Vinci Surgical System ◽  
Vinci Surgical System ◽  
Surgical System

scholarly journals Introduction of the Robotic Surgery (da Vinci Surgical System) for Colorectal Cancer

2016 ◽  
Vol 66 (2) ◽  
pp. 155-158
Author(s):  
Tsunehiko Maruyama ◽  
Akihiro Sako ◽  
Kazumitsu Ueda ◽  
Minoru Okumura ◽  
Nobuhiro Ohkohchi
Keyword(s):  
Colorectal Cancer ◽  
Robotic Surgery ◽  
Da Vinci ◽  
Da Vinci Surgical System ◽  
Vinci Surgical System ◽  
Surgical System

Trends in the adoption of robotic technology in the surgical management of prostate cancer: A population-based analysis.

2012 ◽  
Vol 30 (5_suppl) ◽  
pp. 258-258
Author(s):  
Steven Lee Chang ◽  
Wei Jiang ◽  
Benjamin I. Chung
Keyword(s):  
Prostate Cancer ◽  
Robotic Surgery ◽  
Radical Prostatectomy ◽  
Surgical Management ◽  
Da Vinci ◽  
Population Based ◽  
Da Vinci Surgical System ◽  
Robotic Technology ◽  
Vinci Surgical System ◽  
Surgical System

258 Background: The adoption of the da Vinci Surgical System (Intuitive Surgical, Inc) for robotic surgery requires a substantial financial investment by hospitals, acquisition of new surgical skills by surgeons, and demand from patients. Although the benefits of this technology have been previously described, the prevalence and adoption rate for the treatment of prostate cancer is not currently known. We performed a population-based analysis to determine how the introduction of robotic technology has altered the surgical management of prostate cancer. Methods: We analyzed patient-level data from the Prospective Rx Comparative Database (Premier, Inc., Charlotte, NC), which collects data from over 600 non-federal hospitals throughout the United States. We captured all men who underwent a radical prostatectomy between January 1, 2003, and December 31, 2010, based on the International Classification of Disease, 9th edition. Radical prostatectomies utilizing the da Vinci Surgical System were identified by a detailed review of the hospital charge data. Descriptive analysis with univariate and multivariate statistical analyses were performed. Results: Prior to 2006, <10% of radical prostatectomies were performed with robotic surgery. Beginning in 2006 there was a rapid rise in adoption reaching 56% utilization in 2009 and leveling off in 2010 to 54%. Adjusted analysis demonstrated that the odds of adopting robotic surgery were higher in teaching hospital (odds ratio [OR] 1.45, p<0.001) and hospitals in the Northeast (vs Midwest [OR 2.99, p<0.001]). Smaller hospitals (<200 beds) had a lower likelihood of adopting robotic surgery (OR 0.4, p<0.001). Patient age had no impact on the odds of undergoing robotic radical prostatectomy. Conclusions: Over past 5 years, there has been widespread adoption of robotic surgery in the management of prostate cancer now with just over half of procedures performed with the da Vinci Surgical System. Our analysis suggests that the adoption of robotic surgery has been determined primarily by the acquisition of this technology by hospitals, which was more common in teaching institutions, larger hospitals, and hospitals in the Northeast.

scholarly journals A Scoping Review of Emerging and Established Surgical Robotic Platforms With Applications in Urologic Surgery

2021 ◽  
pp. 300-310
Author(s):  
Braden Millan ◽  
Shavy Nagpal ◽  
Maylynn Ding ◽  
Jason Y. Lee ◽  
Anil Kapoor
Keyword(s):  
Da Vinci ◽  
Da Vinci Surgical System ◽  
Pubmed Central ◽  
Urologic Surgery ◽  
Additional Information ◽  
Surgery Research ◽  
Robotic Platforms ◽  
Distinct Features ◽  
Vinci Surgical System ◽  
Surgical System

Objectives Since the introduction of the first master–slave robotic platform for surgical procedures, there have been ongoing modifications and development of new platforms, but there is still a paucity of commercially available systems. Our study aims to identify all master–slave robotic surgical platforms currently commercially available or in development around the world with applications in urologic surgery. Methods A scoping literature search was performed using PRISMA methodology to identify all relevant publications in English in PubMed, PubMed Central, and Embase, with additional information being obtained from official company websites. Results Ten robotic platforms with either proven or potential application in urologic surgery were identified: the da Vinci surgical system (Intuitive), Senhance surgical system (Transentrix), Versius Surgical (CMR Ltd), Enos surgical system (Titan Medical), Revo –I (Meere Company), MiroSurge (DLR), Avatera System (Avatera Medical), Hugo Surgical Robot (Medtronic), Ottava (J&J, Ethicon, Areus), and Hinotori (Medicaroid Corporation). Conclusions This review highlights the distinct features of emerging master–slave robotic platforms with applications in urologic surgery. Research and development are now focused on finding wider applications, improving outcomes, increasing availability, and reducing cost. Additional research is required comparing newly developed master–slave robotic platforms with those already well established.

Sign in / Sign up

Export Citation Format

Share Document